Recombinant Human BRCA2 Protein，His

BRCA2, a crucial gene linked to hereditary breast and ovarian cancer, encodes a protein that plays a vital role in the repair of DNA double-strand breaks through homologous recombination. The importance of BRCA2 in maintaining genomic stability has been underscored by its association with an increased risk of developing cancers when mutated. The BRCA2 protein facilitates the recruitment and stabilization of RAD51, a key enzyme involved in the recombination process, thereby preventing genomic instability and tumorigenesis. Research into BRCA2 has expanded over the years, focusing on its molecular mechanisms, role in DNA repair pathways, and implications in cancer therapies such as PARP inhibitors. Understanding the structure and function of BRCA2 is critical, not only for identifying individuals at risk but also for developing targeted treatments that exploit the vulnerabilities in cancer cells with BRCA2 mutations. Recent advancements in protein interaction studies and structural biology have provided deeper insights into BRCA2’s function and its interplay with other proteins involved in the DNA repair machinery, paving the way for innovative therapeutic strategies aimed at enhancing cancer treatment efficacy and personalizing patient care. The ongoing research surrounding BRCA2 continues to unveil its complexity and significance in cancer biology, reinforcing the need for further exploration of its therapeutic potential and the development of genetic screening methods to improve early detection and intervention for at-risk populations.